-
Iran declares European armies 'terrorist groups' after IRGC designation
-
Snowstorm disrupts travel in southern US as blast of icy weather widens
-
Denmark's Andresen swoops to win Cadel Evans Road Race
-
Volkanovski beats Lopes in rematch to defend UFC featherweight title
-
Sea of colour as Malaysia's Hindus mark Thaipusam with piercings and prayer
-
Exiled Tibetans choose leaders for lost homeland
-
Afghan returnees in Bamiyan struggle despite new homes
-
Mired in economic trouble, Bangladesh pins hopes on election boost
-
Chinese cash in jewellery at automated gold recyclers as prices soar
-
Israel to partially reopen Gaza's Rafah crossing
-
'Quiet assassin' Rybakina targets world number one after Melbourne win
-
Deportation raids drive Minneapolis immigrant family into hiding
-
Nvidia boss insists 'huge' investment in OpenAI on track
-
'Immortal' Indian comics keep up with changing times
-
With Trump mum, last US-Russia nuclear pact set to end
-
In Sudan's old port of Suakin, dreams of a tourism revival
-
Narco violence dominates as Costa Rica votes for president
-
Snowstorm barrels into southern US as blast of icy weather widens
-
LA Olympic chief 'deeply regrets' flirty Maxwell emails in Epstein files
-
Rose powers to commanding six-shot lead at Torrey Pines
-
Barca wasteful but beat Elche to extend Liga lead
-
Konate cut short compassionate leave to ease Liverpool injury crisis
-
Separatist attacks in Pakistan kill 33, dozens of militants dead
-
Dodgers manager Roberts says Ohtani won't pitch in Classic
-
Arsenal stretch Premier League lead as Chelsea, Liverpool stage comebacks
-
Korda defies cold and wind to lead LPGA opener
-
New head of US mission in Venezuela arrives as ties warm
-
Barca triumph at Elche to extend Liga lead
-
Ekitike, Wirtz give Liverpool sight of bright future in Newcastle win
-
West Indies 'tick boxes' in shortened T20 against South Africa
-
Chelsea have something 'special' says Rosenior
-
De Zerbi 'ready to go to war' to solve Marseille troubles
-
Hornets hold off Wemby's Spurs for sixth NBA win in a row
-
Moyes blasts killjoy booking after Everton's late leveller
-
Ex-prince Andrew again caught up in Epstein scandal
-
Bayern held at Hamburg to open door for Dortmund
-
Atletico stumble to draw at Levante, Villarreal held
-
Chelsea stage impressive fightback to beat West Ham
-
Arsenal stretch Premier League lead, Chelsea fightback breaks Hammers' hearts
-
Napoli edge Fiorentina as injury crisis deepens
-
How Lego got swept up in US-Mexico trade frictions
-
UK rights campaigner Tatchell arrested at pro-Palestinian protest
-
Iran says progress made towards US talks despite attack jitters
-
'Empowering': Ireland's first female sumo wrestler blazes a trail
-
US judge denies Minnesota bid to suspend immigration sweeps
-
Ukraine hit by mass power outages after 'technical malfunction'
-
AC Milan prolong France 'keeper Maignan deal by five years
-
Arteta hails Arsenal's statement rout of Leeds
-
Marseille buckle as Paris FC battle back for draw
-
Protesters demand 'justice' one month after Swiss bar fire
Sannabis, Inc. (OTC:USPS) Announces Supplier Agreement with Licensed Colombian Grower to Stock Sannabis Human Fine Clinics and Pharmacy
Sannabis S.A.S. doctors will lead nationwide medical cannabis education as Colombia enters a new regulatory phase for cannabis flower distribution.
CALI, CO / ACCESS Newswire / November 24, 2025 / Sannabis, Inc., f/k/a Ultimate Sports, Inc. (OTC:USPS), a U.S. Company (the "Company") planning to acquire Sannabis S.A.S ("Sannabis") in Colombia, is pleased to announce that Sannabis has entered into a supply agreement with a licensed Colombian cannabis cultivator to provide Sannabis-branded cannabis flower for distribution through the Sannabis Human Fine IPS Health Clinics and the Sannabis Human Fine Pharmacy-expected to be among the first authorized dispensaries in Colombia.
Under this new agreement, Sannabis will receive a consistent supply of high-quality, compliant cannabis flower cultivated specifically for medical use. The product will be used in the Human Fine's clinics, in partnership with Sannabis, for patient prescriptions and distributed through its pharmacy in accordance with upcoming national regulations.
Medical Leadership: Sannabis Doctors to Train Physicians Nationwide
To support the safe, effective, and compliant rollout of medical cannabis flower nationwide, Sannabis' medical team will begin hosting professional workshops for physicians, providing training on:
How to prescribe cannabis flower responsibly
Matching cannabinoid profiles to individual patient needs
Safe integration of cannabis oil and flower into treatment plans
Standard-of-care protocols for chronic pain, anxiety, sleep disorders, and other conditions
These workshops position Sannabis as a leader in Colombia's evolving medical cannabis ecosystem.
Advancing National Policy-Continuing a Legacy From 2015
Sannabis has formally submitted regulatory proposals to the Ministry of Justice outlining a structured, transparent framework for commercial cannabis distribution. This continues the Company's longstanding role in shaping Colombian cannabis regulations.
In 2015, Sannabis hosted national and regional government officials at its operations on an Indigenous Reservation, contributing directly to the protocols used in Colombia's first cannabis legalization decree.
"Now that Colombia is regulating cannabis flower for medical distribution, Sannabis is once again stepping up with constructive, experience-based recommendations that prioritize patient access, product safety, and transparent oversight," said Juan P. Guzman, CEO of Sannabis, Inc. and Director of Sannabis S.A.S.
Upcoming Distribution Announcements
Sannabis will announce its commercial distribution plan once the Ministry finalizes regulations and approves the Sannabis proposed protocols. Initial plans include expanding pharmacy operations, scaling supply capacity, and establishing distribution routes through health-sector partners.
The Sannabis Human Fine Pharmacy will operate within the temporary regulatory window granted to pharmacies authorized to dispense cannabis flower with a prescription, putting Sannabis in an early-mover position to serve medical patients across Colombia.
Colombia now has a complete regulatory framework, with certified seeds, planted by licensed cultivators, of flowers being dispensed by licensed authorized pharmacies.
For more information, visit www.sannabis.co, or follow Sannabis on social media for updates on the acquisition, product launches, and international initiatives.
About Sannabis, Inc. (OTC:USPS)
Sannabis, Inc. (OTC: USPS), formerly Ultimate Sports, Inc., is a U.S.-based company focused on the legal cannabis and hemp industry in Colombia. The company is finalizing the acquisition of Sannabis S.A.S. in Colombia, a fully licensed, vertically integrated cannabis producer and innovator with a strong commitment to social and environmental responsibility. Sannabis, Inc. has amended their articles of incorporation with the Indiana Secretary of State and changed their name from Ultimate Sports, Inc. A name change action has been initiated with FINRA which is still open. Until approved, they will trade as Ultimate Sports, Inc. (OTC: USPS), they plan to keep the USPS stock symbol.
Media Contact:
Investor Relations
Sannabis, Inc.
Email: [email protected]
Website: www.Sannabis.co
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other applicable securities laws. Forward-looking statements are based on current expectations, estimates, and projections about the business and industry of Sannabis, Inc. or Sannabis S.A.S., as well as management's beliefs and assumptions. Words such as "expects," "intends," "plans," "anticipates," "believes," "projects," "potential," "may," "will," "should," and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve certain risks, uncertainties, and assumptions that are difficult to predict. Actual results and outcomes may differ materially from those expressed or implied by such forward-looking statements, including but not limited to: the completion of the acquisition of Sannabis S.A.S.; the timing and impact of regulatory approvals in Colombia and other jurisdictions; the commercial success of Sannabis products and SannaCoin; the ability to secure financing; and general economic and market conditions. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. Except as required by law, Sannabis, Inc. or Sannabis S.A.S. undertake no obligation to update or revise any forward-looking statements to reflect new information, future events, or otherwise.
SOURCE: Sannabis S.A.S.
View the original press release on ACCESS Newswire
K.Hill--AT